E-LIB Suche - Ergebnisse für: Amiot, A

1

DOP79 Promising efficacy of biologicals and small molecules..:

Verstockt ., B ; Taelman, T ; Vavricka, S R...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i219-i221 , 2024

Link: https://doi.org/10.1093/..

2

Infliximab is an effective option in patients with ulcerati..:

Hupé, M. ; Streichenberger, A. ; Wils, P....
Digestive and Liver Disease. , 2024

Link: https://doi.org/10.1016/..

3

P1141 Global perspectives on managing Inflammatory Bowel Di..:

Casanova, M J ; Gisbert, J P ; Amiot, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i2042-i2044 , 2024

Link: https://doi.org/10.1093/..

4

P322 Compared Efficacy of Second-Line Treatments for Ulcera..:

Calmejane, L ; Reenaers, C ; Amiot, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i707-i707 , 2024

Link: https://doi.org/10.1093/..

5

P663 Efficacy of jak inhibitors in inflammatory bowel disea..:

Livne Margolin, M ; González Lama2, Y ; Koutroubakis, I...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1261-i1263 , 2024

Link: https://doi.org/10.1093/..

6

P386 Persistence of bowel urgency despite clinical remissio..:

Buisson, A ; Amiot, A ; Nachury, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i812-i812 , 2024

Link: https://doi.org/10.1093/..

7

P508 Pre-operative exposure to tofacitinib is as safe as bi..:

Dragoni, G ; Innocenti, T ; Amiot, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1005-i1006 , 2024

Link: https://doi.org/10.1093/..

8

P510 Relapse rate following withdrawal of vedolizumab and u..:

Albshesh, A ; Kucha, P ; Mahajna, H...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1009-i1010 , 2024

Link: https://doi.org/10.1093/..

9

DOP65 Infliximab plus azathioprine and quick steroids disco..:

Amiot, A ; Seksik, P ; Meyer, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i191-i191 , 2024

Link: https://doi.org/10.1093/..

10

DOP23 The role of histology for the prediction of clinical ..:

Reenaers Dr, C ; Enea, D ; Nachury, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i117-i117 , 2024

Link: https://doi.org/10.1093/..

11

DOP89 Impact of biologics on the risk of early postoperativ..:

Fumery, M ; Nancey, S ; Nachury, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i166-i167 , 2023

Link: https://doi.org/10.1093/..

12

P443 Risk of incident Cancer in Patients with Inflammatory ..:

Le Cosquer, G ; Gilletta, C ; Amiot, A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i572-i572 , 2023

Link: https://doi.org/10.1093/..

13

P778 Effectiveness and safety of a second-line rescue thera..:

García, M J ; Riestra, S ; Amiot, A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i911-i912 , 2023

Link: https://doi.org/10.1093/..

14

P579 Real-world comparison of effectiveness between tofacit..:

Buisson, A ; Serrero, M ; Altwegg, R...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i707-i707 , 2023

Link: https://doi.org/10.1093/..

15

How to Manage Inflammatory Bowel Disease Patients When They..:

Cottron, C ; Treton, X ; Altwegg, R...
Journal of Crohn's and Colitis. 16 (2022) 8 - p. 1202-1210 , 2022

Link: https://doi.org/10.1093/..